Imricor Medical Systems, Inc.
Imricor Medical Systems, Inc.
Your view on IMR.AX
Overview
What the company does, where it operates, and who runs it.
About Imricor Medical Systems, Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Steven Wedan
- Headquarters
- 400 Gateway Boulevard, Burnsville, MN, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Steven Wedan
- Headquarters
- 400 Gateway Boulevard, Burnsville, MN, US
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Imricor Medical Systems, Inc., and the rating behind it. IMR.AX last traded at AUD 1.90; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Imricor Medical Systems, Inc.. Starting points for Imricor Medical Systems, Inc.: EPS -AUD 0.15, beta 0.46 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Imricor Medical Systems, Inc.. Trailing twelve-month EPS for Imricor Medical Systems, Inc. stands at -AUD 0.15. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Imricor Medical Systems, Inc. valued side by side against its closest peers. Imricor Medical Systems, Inc. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Imricor Medical Systems, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Imricor Medical Systems, Inc. executives and directors. Shares of Imricor Medical Systems, Inc. have traded between AUD 1.27 and AUD 2.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Imricor Medical Systems, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Imricor Medical Systems, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Imricor Medical Systems, Inc.. Coverage tracks Imricor Medical Systems, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.